Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, South Korea.
Eur Rev Med Pharmacol Sci. 2022 Nov;26(21):7734-7741. doi: 10.26355/eurrev_202211_30122.
Recent evidence shows that indicators testing conventional olfactory function have a high degree of similarity to cognitive function tests and the potential to diagnose early-stage Alzheimer's disease (AD). In this study, the efficacy of functional near-infrared spectroscopy time-series data obtained through olfactory stimulation was investigated as an early diagnostic tool for mild cognitive impairment in AD using random forest, a machine learning algorithm.
We conducted a patient-level, single-group, diagnostic interventional trial using near-infrared signals measured during olfactory stimulation in the prefrontal cortex of 178 older adults ranging from normal to participants with AD as markers to discriminate AD stages. We first divided the participants into normal older adults, AD mild cognitive impairment, and AD groups using dementia diagnostic criteria such as the Mini-Mental State Examination and Seoul Neuropsychological Screening Battery. We compared the left and right oxygenation difference by calculating the relative oxygenation difference from the change in relative oxygen concentration.
A total of 168 participants met the eligibility criteria: 70 (41.6%) had normal cognitive function; 42 (25%) mild cognitive impairment; 21 (12.5%) mild AD; and 35 (20.8%) moderate AD. A random forest machine learning model was developed to predict the AD stage, with an area under the receiver operating characteristic curve of 90.7% for mild cognitive impairment and AD, 90.99% for mild cognitive impairment, and 93.34% for AD only.
Based on the classification of the oxygenation difference index of the left and right prefrontal cortices during olfactory stimulation through machine learning, we found that it was possible to detect early-stage mild cognitive impairment in AD. Our results highlight the potential for early AD diagnosis using near-infrared signals from the prefrontal cortex obtained upon olfactory stimulation. Moreover, the results showed high similarity to the existing cognitive function tests and high accuracy in AD stage classification.
最近的证据表明,测试传统嗅觉功能的指标与认知功能测试具有高度相似性,并且有可能诊断早期阿尔茨海默病(AD)。在这项研究中,我们使用机器学习算法随机森林研究了通过嗅觉刺激获得的近红外光谱时间序列数据作为 AD 轻度认知障碍早期诊断工具的功效。
我们使用近红外信号进行了一项患者水平、单组、诊断性干预试验,这些信号是在前额叶皮层中通过嗅觉刺激获得的,作为标记物来区分 AD 阶段,参与者为从正常到 AD 患者的 178 名老年人。我们首先使用痴呆症诊断标准(如简易精神状态检查和首尔神经心理筛选测验)将参与者分为正常老年人、AD 轻度认知障碍和 AD 组。我们通过计算相对氧浓度变化的相对氧差异来比较左右氧合差异。
共有 168 名参与者符合入选标准:70 名(41.6%)认知功能正常;42 名(25%)轻度认知障碍;21 名(12.5%)轻度 AD;35 名(20.8%)中度 AD。我们开发了一种随机森林机器学习模型来预测 AD 阶段,其对轻度认知障碍和 AD 的受试者工作特征曲线下面积为 90.7%,对轻度认知障碍为 90.99%,对 AD 为 93.34%。
基于机器学习对嗅觉刺激时左右前额叶皮层氧合差异指数的分类,我们发现有可能检测到 AD 的早期轻度认知障碍。我们的结果强调了使用嗅觉刺激获得的前额叶近红外信号进行早期 AD 诊断的潜力。此外,结果与现有的认知功能测试高度相似,并且在 AD 阶段分类方面具有很高的准确性。